1. Service Fee
We charge a flat fee for the ion redundancy evaluation service (IRES) based on the number of target proteins. The deliverable is a .csv file listing the theoretical peptides for the target protein ranked by the ion redundancy hits against the background proteome (see excerpt below). The turnaround time is typically within 3 business days after receiving the order. An invoice will be sent to you by email along with the deliverable .csv file.
| Number of Target Proteins | Flat Fee (USD) |
| 1 to 10 | 500.00 |
| 11 to 20 | 550.00 |
| 21 to 30 | 600.00 |
| 31 to 40 | 650.00 |
| 41 to 50 | 700.00 |
| 51 to 60 | 750.00 |
| 61 to 70 | 800.00 |
| 71 to 80 | 850.00 |
| 81 to 90 | 900.00 |
| 91 to 100 | 950.00 |
| over 100 | Please contact us |
2. Deliverable (excerpt of a sample deliverable file with header explanation)
Protein the target protein being measured in study sample
ACC NUM UniProtKB accession number (for recombinant protein, an arbitrary number is assigned)
Peptide the theoretical tryptic peptide derived from target protein
Q1 (m/z) doubly charged precursor m/z
Q3 (m/z) singly charged product ion m/z
Q3 Name product ion name
Hits the number of redundant (i.e. indistinguishable) transitions identified in background proteome, self-inclusive
Hits Detail a list of all the identified redundant product ions displaying accession number, peptide sequence, product ion name, and product ion m/z
| Protein | ACC NUM | Peptide | Q1 (m/z) | Q3 (m/z) | Q3 Name | Hits | Hits Detail |
| Bevacizumab | BEVAH56 | FTFSLDTSK | 523.25 | 396.18 | b3 | 3 | P07339_QPGITFIAAK_b4_396.22;BEVAH56_FTFSLDTSK_b3_396.18;P26045_KPGLAITFAK_b4_396.25 |
| Bevacizumab | BEVAH56 | FTFSLDTSK | 523.25 | 483.22 | b4 | 3 | BEVAH56_FTFSLDTSK_b4_483.22;Q96SN8_AIQGLTMALK_b5_483.29;A6NES4_TMLHSLMGR_b4_483.23 |
| Bevacizumab | BEVAH56 | FTFSLDTSK | 523.25 | 596.30 | b5 | 1 | BEVAH56_FTFSLDTSK_b5_596.30 |
| Bevacizumab | BEVAH56 | FTFSLDTSK | 523.25 | 711.33 | b6 | 3 | BEVAH56_FTFSLDTSK_b6_711.33;Q9NYF3_SSPASSPELPWRPR_y5_711.39;Q8WXH0_ALVSNLISTK_b7_711.43 |
| Bevacizumab | BEVAH56 | FTFSLDTSK | 523.25 | 812.38 | b7 | 5 | Q13510_HPFFLDDR_y6_812.38;BEVAH56_FTFSLDTSK_b7_812.38;Q9NQC3_ISFSDDFSK_b7_812.34;Q96RT8_FVIHSDLSK_b7_812.42;Q6PIW4_QIVINLMSK_b7_812.46 |
| Bevacizumab | BEVAH56 | FTFSLDTSK | 523.25 | 899.41 | b8 | 43 | Q01082_LEMNLGLQK_b8_899.46;Q15428_FWTHWNR_y6_899.41;P07339_QPGITFIAAK_b9_899.49;Q8NER5_NIVTVAGMIK_b9_899.49;Q8TEA7_ICILDGGINK_b9_899.46;BEVAH56_FTFSLDTSK_b8_899.41;O43264_LSEDIDLLK_b8_899.46;Q9Y2K2_LIAECQQLK_b8_899.46;Q6NXR0_LAAEILCQGK_b9_899.46;Q5VYM1_VAFLDHLCK_b8_899.44;O75582_INWDDLAAK_b8_899.42;Q92968_AGDMLNLALK_b9_899.46;Q86T24_SDLLDELIK_b8_899.46;P08729_WTLLQEQK_b7_899.45;Q9H598_QGLQMDILK_b8_899.46;Q9NRD5_AILCNDGLVK_b9_899.46;Q5T4B2_HQFLMELK_b7_899.44;O14744_DWNTLIVGK_b8_899.45;Q9NQC3_ISFSDDFSK_b8_899.37;Q3KQZ1_TEGIFGMYK_b8_899.39;P04114_IPSVQINFK_b8_899.49;A8MT19_GPLSVFLANK_b9_899.49;P57071_DFMCELCGK_b8_899.30;Q9Y587_TLLETEVIK_b8_899.50;Q8N490_MAAVVAATALK_b10_899.49;Q8NB66_SALEVVWNK_b8_899.45;Q9NVN8_AVLADWVSGK_b9_899.45;Q96RT8_FVIHSDLSK_b8_899.45;Q96SN8_AIQGLTMALK_b9_899.49;P46109_GLFPFTHVK_b8_899.47;Q9UL49_EFESVFCGK_b8_899.35;Q6XZF7_WLIDNGVTK_b8_899.45;Q6PIW4_QIVINLMSK_b8_899.49;Q6ZTR5_HFRPIFTK_b7_899.48;P06400_STSLSLFYK_b8_899.44;Q8WXH0_ALVSNLISTK_b9_899.51;P26045_KPGLAITFAK_b9_899.53;Q9HAU5_GAPNADLIFK_b9_899.45;Q9Y3R0_ILAINSSSLK_b9_899.51;Q5TEZ5_YINYTFPK_b7_899.42;Q69YN4_VDLIELSEK_b8_899.46;O75976_ESLITLIEK_b8_899.50;O60678_LEDTITLIK_b8_899.50 |
| Bevacizumab | BEVAH56 | FTFSLDTSK | 523.25 | 335.17 | y3 | 2 | BEVAH56_FTFSLDTSK_y3_335.17;Q8WXH0_ALVSNLISTK_y3_335.17 |
| Bevacizumab | BEVAH56 | FTFSLDTSK | 523.25 | 450.20 | y4 | 2 | BEVAH56_FTFSLDTSK_y4_450.20;Q969R8_AFCAGLYACK_b5_450.17 |
| Bevacizumab | BEVAH56 | FTFSLDTSK | 523.25 | 563.29 | y5 | 4 | BEVAH56_FTFSLDTSK_y5_563.29;Q969R8_AFCAGLYACK_b6_563.26;Q96SN8_AIQGLTMALK_y5_563.30;A6NES4_TMLHSLMGR_y5_563.28 |
| Bevacizumab | BEVAH56 | FTFSLDTSK | 523.25 | 650.32 | y6 | 4 | P07339_QPGITFIAAK_y6_650.37;BEVAH56_FTFSLDTSK_y6_650.32;Q9NQ36_GSVACECRPGFELAK_b7_650.22;P26045_KPGLAITFAK_y6_650.37 |
| Bevacizumab | BEVAH56 | FTFSLDTSK | 523.25 | 797.39 | y7 | 4 | P12956_QELLEALTK_b7_797.43;BEVAH56_FTFSLDTSK_y7_797.39;Q969R8_AFCAGLYACK_b8_797.36;Q02833_EESLLGAPSESHAGAQPRPR_b8_797.40 |
| Bevacizumab | BEVAH56 | FTFSLDTSK | 523.25 | 898.43 | y8 | 27 | Q8IVG5_QVSLPEMIK_b8_898.46;P20073_SEIDLVQIK_b8_898.48;Q5VT79_SEIDLNLIK_b8_898.48;Q6IC98_LVDITDIQK_b8_898.48;P12956_QELLEALTK_b8_898.48;O95071_AAVIIMAVEK_b9_898.50;BEVAH56_FTFSLDTSK_y8_898.43;Q8NEV4_AGLDNWALGK_b9_898.43;Q6IS24_LPQLLDCDK_b8_898.43;Q8WXX0_LILDNDTIK_b8_898.48;Q15021_ITEAIGIISK_b9_898.52;P10644_VLGPCSDILK_b9_898.46;Q96RT8_FVIHSDLSK_y8_898.48;Q8NCM8_TVIDDLIQK_b8_898.48;Q8WZ42_DLSLVVTGLK_b9_898.52;Q8TCG1_NEELSVLLK_b8_898.48;Q9Y2G4_QISLVDELK_b8_898.48;Q9UPN3_SELNLLVEK_b8_898.48;Q8IX90_DDVNILLDK_b8_898.44;Q5THJ4_ALLACQGQLK_b9_898.47;Q9UGI0_RPIIVYGVK_b8_898.54;P13928_SEIDLNLIK_b8_898.48;Q96GQ5_ATWLLSPEK_b8_898.46;O75051_QLLSDLIDK_b8_898.48;O14727_VWNIITGNK_b8_898.47;Q2V2M9_QEIIVLDSK_b8_898.48;Q9BYX2_VLQDLLSEK_b8_898.48 |
| ERCC3 | P19447 | INTIFISK | 468.27 | 329.17 | b3 | 7 | P59044_VQTLFLSK_b3_329.17;O43482_SLGAVVFSR_b4_329.17;P22736_MPCIQAQYGTPAPSPGPR_y3_329.18;Q5T200_LAGSELFAK_b4_329.17;Q56VL3_QSLLFCPK_b3_329.17;Q9BXM7_GGNGCLMAPEVSTARPGPR_y3_329.18;P19447_INTIFISK_b3_329.17 |
| ERCC3 | P19447 | INTIFISK | 468.27 | 442.26 | b4 | 4 | Q9Y6F1_LITNIFSK_b4_442.26;P59044_VQTLFLSK_b4_442.26;Q56VL3_QSLLFCPK_b4_442.26;P19447_INTIFISK_b4_442.26 |
| ERCC3 | P19447 | INTIFISK | 468.27 | 589.33 | b5 | 10 | Q70UQ0_FLSLEGDR_y5_589.28;Q93034_AYIVEWR_y4_589.29;P59044_VQTLFLSK_b5_589.33;Q5CZC0_LFQLSSLK_b5_589.33;P40189_YLATLTVR_y5_589.35;Q56VL3_QSLLFCPK_b5_589.33;O43361_FFMYNSK_b4_589.24;P19447_INTIFISK_b5_589.33;Q6NXT6_FLSAELTR_y5_589.31;Q86WG5_LFSLGAGDR_b6_589.33 |
| ERCC3 | P19447 | INTIFISK | 468.27 | 702.41 | b6 | 8 | Q9BRK3_AYGPLFLR_y6_702.41;Q9Y6F1_LITNIFSK_b6_702.41;Q93034_AYIVEWR_y5_702.38;P59044_VQTLFLSK_b6_702.41;P24386_FNIDLVSK_b6_702.37;P19447_INTIFISK_b6_702.41;Q9Y6D5_DLYVNPNHQTSLGQER_b6_702.34;P26374_FNIDLVSK_b6_702.37 |
| ERCC3 | P19447 | INTIFISK | 468.27 | 789.44 | b7 | 34 | Q66GS9_WESLMAAK_b7_789.35;Q9Y6F1_LITNIFSK_b7_789.44;Q70UQ0_FLSLEGDR_y7_789.39;P78363_NISDFLVK_b7_789.41;Q8WW43_LCLLCQDK_b7_789.36;P59044_VQTLFLSK_b7_789.44;O00268_NFLSTLIK_b7_789.44;Q14689_LAYTLLNK_b7_789.44;Q96PG2_NLHLVVLK_b7_789.49;Q6AHZ1_ISGFGTLLK_b8_789.44;Q5T0T0_VYVQLWK_b6_789.42;P53677_MLSWDVGK_b7_789.35;Q86TM3_QLALSYLK_b7_789.44;Q5CZC0_LFQLSSLK_b7_789.44;P24386_FNIDLVSK_b7_789.41;Q8IZD9_FVLSLDSR_y7_789.43;O43896_WATMADLK_b7_789.35;Q9NVD7_TLITFVNK_b7_789.44;Q5T200_LAGSELFAK_b8_789.41;Q56VL3_QSLLFCPK_b7_789.39;Q9BQJ4_FIETVSLK_y7_789.45;P52179_DSMVLGWK_b7_789.35;Q8TBC4_QFLFRPK_b6_789.43;O43361_FFMYNSK_y6_789.34;Q9P265_LAYTLLNK_b7_789.44;Q96I51_GELFVWGK_b7_789.39;P19447_INTIFISK_b7_789.44;Q5T9G4_LLSYLAQK_b7_789.44;Q6P3R8_FQELPFR_y6_789.41;Q6NXT6_FLSAELTR_y7_789.43;O95747_MISLCLQK_b7_789.39;Q8IZY2_NLSDFLVK_b7_789.41;P26374_FNIDLVSK_b7_789.41;Q63ZY3_SSGLSTPVPPSAGHLAHVR_y7_789.43 |
| ERCC3 | P19447 | INTIFISK | 468.27 | 347.21 | y3 | 9 | Q70UQ0_FLSLEGDR_y3_347.15;P59044_VQTLFLSK_y3_347.21;Q5CZC0_LFQLSSLK_y3_347.21;Q9HD20_EFVITSLK_y3_347.21;Q56VL3_QSLLFCPK_y3_347.16;Q9BQJ4_FIETVSLK_y3_347.21;P19447_INTIFISK_y3_347.21;O60281_QLQEMKPTVSLK_y3_347.21;Q86WG5_LFSLGAGDR_y3_347.15 |
| ERCC3 | P19447 | INTIFISK | 468.27 | 494.28 | y4 | 6 | Q9Y6F1_LITNIFSK_y4_494.28;P59044_VQTLFLSK_y4_494.28;O75715_TDILAYLK_y4_494.28;Q56VL3_QSLLFCPK_y4_494.23;P19447_INTIFISK_y4_494.28;Q75QN2_SELLSFIK_y4_494.28 |
| ERCC3 | P19447 | INTIFISK | 468.27 | 607.36 | y5 | 8 | P59044_VQTLFLSK_y5_607.36;O43482_SLGAVVFSR_y5_607.34;O75715_TDILAYLK_y5_607.36;Q5T200_LAGSELFAK_y5_607.33;Q56VL3_QSLLFCPK_y5_607.31;P19447_INTIFISK_y5_607.36;Q75QN2_SELLSFIK_y5_607.36;Q86SQ4_TIDELAFK_y5_607.33 |
| ERCC3 | P19447 | INTIFISK | 468.27 | 708.41 | y6 | 6 | P78363_NISDFLVK_y6_708.37;P59044_VQTLFLSK_y6_708.41;Q96PG2_NLHLVVLK_y6_708.46;Q8IYW2_LDSLGLYR_y6_708.39;P19447_INTIFISK_y6_708.41;Q8IZY2_NLSDFLVK_y6_708.37 |
| ERCC3 | P19447 | INTIFISK | 468.27 | 822.45 | y7 | 16 | O77932_LARPPLLR_y7_822.51;Q9UGI0_LYALWNR_y6_822.41;Q9Y6F1_LITNIFSK_y7_822.45;Q8WW43_LCLLCQDK_y7_822.37;C9JTQ0_LPRPLLAR_y7_822.51;Q14689_LAYTLLNK_y7_822.45;Q6AHZ1_ISGFGTLLK_y8_822.45;Q5CZC0_LFQLSSLK_y7_822.45;P42331_NWDFNLK_y6_822.40;Q5T200_LAGSELFAK_y8_822.42;Q9BTN0_LPLLARPR_y7_822.51;Q9P265_LAYTLLNK_y7_822.45;P19447_INTIFISK_y7_822.45;Q5T9G4_LLSYLAQK_y7_822.45;Q8N8A6_LLQPLVPR_y7_822.50;Q86WG5_LFSLGAGDR_y8_822.39 |
3. Place An Order
Please provide the information below to place an order. Currently, the protein digestion is limited to Trypsin. If you are interested in an enzyme other than Trypsin, please let us know in Special Note.